Home Dialysis News

UK-based Quanta Fluid Solutions Ltd said it has successfully treated the first patients with SC+, its portable, cartridge-based hemodialysis system. The treatments were part of a pilot study designed to demonstrate safety, performance and usability of SC+ in a clinical setting with human dialysis patients. The results showed that all dialysis therapies were successfully and safely completed with no adverse events.

The United States Food and Drug Administration has granted 510(k) clearance to Baxter International Inc.'s AMIA automated peritoneal dialysis (APD) system with the Sharesource web-based remote connectivity platform. The device is approved to provide peritoneal dialysis for the treatment of end-stage renal disease.

A story in September detailed the work of Anya Pogharian on a new portable hemodialysis machine. The 18-year-old from Montreal is collaborating with Héma-Québec, which manages the blood supply of Quebec, to test the machine, which she built for $500 for a science fair, CBC News Montreal reported.

INDIANAPOLIS–Dialysis can take a toll on your well-being. Three times a week, 3-4 hours a treatment, doesn't do a good job of replacing natural kidney function. You can feel the effects of fluid overload between treatments, and experience the exhaustion after each treatment.

Northwest Kidney Centers has named a conference room at one of its Seattle dialysis clinics after home dialyzor Bill Peckham to commemorate his 25-year dialysis anniversary. The Bill Peckham Home Dialysis Conference Room was paid for by donors, including Dialysis Clinic Inc., who also donated money to kidney research. NxStage is donating Peckham's well-traveled dialysis machine to Northwest Kidney Centers' dialysis museum.

Canadian patients who received in center nocturnal dialysis saw a significant reduction in left ventricular mass after one year, compared to patients on conventional dialysis, according to a new study published in the Canadian Journal of Cardiology. 

Editor’s note: This article was originally published Sept. 3 on Home Dialysis Central’s KidneyViews blog. 

Seventeen-year-old Anya Pogharian from Montreal is working with Héma-Québec, which manages the blood supply of Quebec, to test a $500 portable dialysis machine she created for a science fair, CBC News Montreal reported.

A study published in the American Journal of Kidney Diseases has demonstrated that frequent home hemodialysis patients have a lower risk of death, hospitalization, and therapy attrition than peritoneal dialysis patients.

One thing became abundantly clear after sifting through the 490 comments on the 2016 proposed rule for the ESRD payment system and Quality Incentive Program: the renal community does not think home hemodialysis training is adequately reimbursed.